Short answer · Medically reviewed summary · Last updated: 2026-04-07
The prevalence of Niemann-Pick disease is estimated to be approximately 1 in 100,000 to 250,000 individuals worldwide, though these figures vary significantly depending on the specific subtype and population studied. Incidence and Distribution Niemann-Pick disease encompasses a group of inherited metabolic disorders characterized by the accumulation of lipids within cells. Type A and B are categorized as Acid Sphingomyelinase Deficiency (ASMD), while Type C is a distinct lipid trafficking disorder.
The prevalence of Niemann-Pick disease is estimated to be approximately 1 in 100,000 to 250,000 individuals worldwide, though these figures vary significantly depending on the specific subtype and population studied.
Niemann-Pick disease encompasses a group of inherited metabolic disorders characterized by the accumulation of lipids within cells. Type A and B are categorized as Acid Sphingomyelinase Deficiency (ASMD), while Type C is a distinct lipid trafficking disorder. Because these are rare, global incidence rates are difficult to pinpoint; however, Niemann-Pick disease is clinically classified as a rare condition. There is no significant gender bias, as the condition affects males and females equally due to its autosomal recessive inheritance pattern.
The age of onset for Niemann-Pick disease is highly variable, ranging from severe infantile presentations (Type A) to childhood-onset (Type B) and a wide spectrum of onset for Type C, which can manifest from infancy through adulthood. While the disease occurs globally, specific populations show higher carrier frequencies. For instance, Niemann-Pick disease Type A has a higher prevalence in individuals of Ashkenazi Jewish descent, while Type C is found worldwide with no specific ethnic predilection.
Accurate prevalence data for Niemann-Pick disease remain a challenge due to frequent underdiagnosis and misdiagnosis. Early symptoms can be non-specific, leading to diagnostic delays. At DiseaseMaps.org, we currently support 64 community members living with Niemann-Pick disease; this real-world data provides a vital, living perspective that complements clinical literature by capturing the lived experience of those navigating these diagnostic hurdles.
Medical Disclaimer: This information is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.